Blood Stem Cell & Bone Marrow Transplantation
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
18
NCT06786533
Clinical Study of Anti-FLT3 CAR-T Cells for the Treatment of Relapsed/Refractory AML
Phase: Phase 1
Role: Lead Sponsor
Start: Jan 23, 2025
Completion: Jan 31, 2027
Loading map...